169310-73-0

Basic information

• Product Name: Benzene, 1-methoxy-4-[(3-methyl-3-butenyl)oxy]-
• Synonyms: 1-methoxy-4-(3-methylbut-3-enyloxy)benzene;1-(4-methoxyphenoxy)-3-methyl-3-butene;1-methoxy-4-[(3-methylbut-3-en-1-yl)oxy]benzene;Benzene,1-methoxy-4-[(3-methyl-3-butenyl)oxy]
• CAS NO: 169310-73-0
• Molecular Formula: C12H16O2
• Molecular Weight: 192.258
• Mol File: 169310-73-0.mol
• Article Data: 13

Chemical Properties

• Melting Point: 57-58 °C
• Boiling Point: 280.9±23.0 °C(Predicted)
• Density: 0.969±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Benzene, 1-methoxy-4-[(3-methyl-3-butenyl)oxy]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1-methoxy-4-[(3-methyl-3-butenyl)oxy]-(169310-73-0)
• EPA Substance Registry System: Benzene, 1-methoxy-4-[(3-methyl-3-butenyl)oxy]-(169310-73-0)

Safety Data

• Hazardous Substances Data: 169310-73-0(Hazardous Substances Data)

Usage

Uses

1-Methoxy-4-[(3-methyl-3-buten-1-yl)oxy]benzene is an intermediate in the synthesis of L-Isomer of Mevalonic acid (M339020), a precursor in the biosynthesis of cholesterol (C432501).

Upstream product

• 80352-66-5 4-mesyloxy-2-methylbutene 
• 150-76-5 4-methoxy-phenol 
• 763-32-6 2-methyl-1-buten-4-ol 

Downstream Products

• 1591632-82-4 (±)-1-(4-methoxyphenoxy)-3-methyl-5-hexyn-3-ol 
• 1591633-05-4 C₂₅H₃₅F₃O₄Si 
• 1591633-09-8 3-tert-butyldimethylsilyloxy-5-ethenyl-3-methylcyclohex-5-en-1-ol 
• 1591632-85-7 3-tert-butyldimethylsilyloxy-5-ethenyl-3-methylcyclohex-5-en-1-ol 
• 1591633-04-3 C₂₅H₃₅F₃O₄Si 
• 1591632-88-0 C₂₅H₃₅NO₄Si 
• 1591632-89-1 C₂₅H₃₅NO₄Si 
• 1591632-90-4 C₁₉H₂₁NO₄ 
• 1591632-91-5 C₂₅H₃₅NO₄Si 
• 1591633-00-9 (+)-5-ethenyl-3-methylcyclohex-5-en-1,3-diol 

Relevant articles and documents

PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF

Provided herein are compounds, compositions, and methods useful for inhibiting protein tyrosine phosphatase, e.g, protein tyrosine phosphatase non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase non-receptor type 1 (PTPN1), and for treating related diseases, disorders and conditions favorably responsive to PTPN1 or PTPN2 inhibitor treatment, e.g, a cancer or a metabolic disease.

7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis

Within a backup program for the clinical investigational agent pretomanid (PA-824), scaffold hopping from delamanid inspired the discovery of a novel class of potent antitubercular agents that unexpectedly possessed notable utility against the kinetoplast

A Ring-Closing Enyne Metathesis Approach to Functionalized Semicyclic Dienes: The Total Synthesis of (-)-Tetrangomycin

The angucycline antibiotic (-)-tetrangomycin was synthesized in 13 steps (11 % overall yield) by using a stereoselective Diels-Alder reaction between a naphthoquinone and a semicyclic diene to construct the benz[a]anthraquinone ring system. The diene inte